MicroRNA-let-7f-1 is induced by lycopene and inhibits cell proliferation and triggers apoptosis in prostate cancer

Li,Danbin; Chen,Lina; Zhao,Wenran; Hao,Jianbing; An,Ruihua

doi:10.3892/mmr.2016.4841

MicroRNA-let-7f-1 is induced by lycopene and inhibits cell proliferation and triggers apoptosis in prostate cancer

Authors:
- Danbin Li
- Lina Chen
- Wenran Zhao
- Jianbing Hao
- Ruihua An
View Affiliations

Affiliations: Department of Urological Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Biophysics, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China, Department of Cell Biology, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China, Department of Nephrology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China
Published online on: February 2, 2016 https://doi.org/10.3892/mmr.2016.4841
Pages: 2708-2714

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies have suggested that lycopene has cytotoxic effects in a variety of types of human cancer. An improved understanding of the mechanisms underlying the anticancer effects of lycopene may provide novel therapeutic targets for cancer treatment. PC3 cells were treated with different concentrations of lycopene for 24 and 48 h, the level of protein kinase B (AKT2) was detected by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blotting. Additionally, the expression levels of microRNA (miR)‑let‑7f‑1 were measured using RT‑qPCR. miR‑let‑7f‑1 function was analyzed using cell proliferation and apoptosis assays in gain‑ and loss‑of‑function experiments. It was observed that lycopene downregulated the expression of AKT2 and upregulated the expression of miR‑let‑7f‑1 in PC3 cells. Re‑introduction of miR‑let‑7f‑1 into PC3 cells was able to inhibit cell proliferation and induce apoptosis. Further investigation indicated that miR‑let‑7f‑1 targeted AKT2 in PC3 cells and upregulation of AKT2 could attenuate the effects induced by miR‑let‑7f‑1. The results of the current study indicate that miR‑let‑7f‑1 is involved in the anticancer effects of lycopene and serves an important role in the inhibition of prostate cancer progression through the downregulation of AKT2.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer Statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
2	Zu K, Mucci L, Rosner BA, Clinton SK, Loda M, Stampfer MJ and Giovannucci E: Dietary lycopene, angiogenesis and prostate cancer: A prospective study in the prostate-specific antigen era. J Natl Cancer Inst. 106:djt4302014. View Article : Google Scholar
3	Wei MY and Giovannucci EL: Lycopene, tomato products and prostate cancer incidence: A review and reassessment in the PSA screening era. J Oncol. 2012:2710632012. View Article : Google Scholar
4	Kristal AR, Till C, Platz EA, Song X, King IB, Neuhouser ML, Ambrosone CB and Thompson IM: Serum lycopene concentration and prostate cancer risk: Results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 20:638–646. 2011. View Article : Google Scholar : PubMed/NCBI
5	Teodoro AJ, Oliveira FL, Martins NB, Maia GA, Martucci RB and Borojevic R: Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines. Cancer Cell Int. 12:362012. View Article : Google Scholar : PubMed/NCBI
6	Hwang ES and Bowen PE: Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J Med Food. 7:284–289. 2004. View Article : Google Scholar : PubMed/NCBI
7	Venkateswaran V and Klotz LH: Diet and prostate cancer: Mechanisms of action and implications for chemoprevention. Nat Rev Urol. 7:442–453. 2010. View Article : Google Scholar : PubMed/NCBI
8	Syed DN, Suh Y, Afaq F and Mukhtar H: Dietary agents for chemoprevention of prostate cancer. Cancer Lett. 265:167–176. 2008. View Article : Google Scholar : PubMed/NCBI
9	Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
10	Ventura A and Jacks T: MicroRNAs and cancer: Short RNAs go a long way. Cell. 136:586–591. 2009. View Article : Google Scholar : PubMed/NCBI
11	Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
12	Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
13	Zhu XC, Dong QZ, Zhang XF, Deng B, Jia HL, Ye QH, Qin LX and Wu XZ: microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma. Int J Mol Med. 30:1321–1326. 2012.PubMed/NCBI
14	Huang B, Luo W, Sun L, Zhang Q, Jiang L, Chang J, Qiu X and Wang E: MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells. Int J Oncol. 42:1734–1742. 2013.PubMed/NCBI
15	Coppola V, De Maria R and Bonci D: MicroRNAs and prostate cancer. Endocr Relat Cancer. 17:F1–F17. 2010. View Article : Google Scholar
16	Rajendiran S, Parwani AV, Hare RJ, Dasgupta S, Roby RK and Vishwanatha JK: MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1. Mol Cancer. 13:2502014. View Article : Google Scholar : PubMed/NCBI
17	Goto Y, Kurozumi A, Enokida H, Ichikawa T and Seki N: Functional significance of aberrantly expressed microRNAs in prostate cancer. Int J Urol. 22:242–252. 2015. View Article : Google Scholar : PubMed/NCBI
18	Jackson BL, Grabowska A and Ratan HL: MicroRNA in prostate cancer: Functional importance and potential as circulating biomarkers. BMC Cancer. 14:9302014. View Article : Google Scholar : PubMed/NCBI
19	Dong Q, Meng P, Wang T, Qin W, Qin W, Wang F, Yuan J, Chen Z, Yang A and Wang H: MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2. PLoS One. 5:e101472010. View Article : Google Scholar : PubMed/NCBI
20	Pannuru P, Dontula R, Khan AA, Herbert E, Ozer H, Chetty C and Lakka SS: miR-let-7f-1 regulates SPARC mediated cisplatin resistance in medulloblastoma cells. Cell Signal. 26:2193–2201. 2014. View Article : Google Scholar : PubMed/NCBI
21	Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX and Shao JY: MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
22	Trejo-Solís C, Pedraza-Chaverrí J, Torres-Ramos M, Jiménez-Farfán D, Cruz Salgado A, Serrano-García N, Osorio-Rico L and Sotelo J: Multiple molecular and cellular mechanisms of action of lycopene in cancer inhibition. Evid Based Complement Alternat Med. 2013:7051212013. View Article : Google Scholar : PubMed/NCBI
23	Tang Y, Parmakhtiar B, Simoneau AR, Xie J, Fruehauf J, Lilly M and Zi X: Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels. Neoplasia. 13:108–119. 2011. View Article : Google Scholar : PubMed/NCBI
24	Lo HM, Hung CF, Tseng YL, Chen BH, Jian JS and Wu WB: Lycopene binds PDGF-BB and inhibits PDGFBB-induced intracellular signaling transduction pathway in rat smooth muscle cells. Biochemical Pharmacology. 74:54–63. 2007. View Article : Google Scholar
25	Chen ML, Lin YH, Yang CM and Hu ML: Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-AKT and ERK/p38 signaling pathways. Molecular Nutrition & Food Research. 56:889–899. 2012. View Article : Google Scholar
26	Livak and Schmittgen: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar
27	Tang FY, Shih CJ, Cheng LH, Ho HJ and Chen HJ: Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway. Mol Nutr Food Res. 52:646–654. 2008. View Article : Google Scholar : PubMed/NCBI
28	Takeshima M, Ono M, Higuchi T, Chen C, Hara T and Nakano S: Anti-proliferative and apoptosis-inducing activity of lycopene against three subtypes of human breast cancer cell lines. Cancer Sci. 105:252–257. 2014. View Article : Google Scholar : PubMed/NCBI
29	Palozza P, Colangelo M, Simone R, Catalano A, Boninsegna A, Lanza P, Monego G and Ranelletti FO: Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines. Carcinogenesis. 31:1813–1821. 2010. View Article : Google Scholar : PubMed/NCBI
30	Carver BS, Chapinski C, Wongvipat J, Hieronymus H, Chen Y, Chandarlapaty S, Arora VK, Le C, Koutcher J, Scher H, et al: Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell. 19:575–586. 2011. View Article : Google Scholar : PubMed/NCBI
31	Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM and Chen CS: The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem. 275:11397–11403. 2000. View Article : Google Scholar
32	Kim DJ, Takasuka N, Kim JM, Sekine K, Ota T, Asamoto M, Murakoshi M, Nishino H, Nir Z and Tsuda H: Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU and DMH. Cancer Lett. 120:15–22. 1997. View Article : Google Scholar
33	Narisawa T, Fukaura Y, Hasebe M, Nomura S, Oshima S, Sakamoto H, Inakuma T, Ishiguro Y, Takayasu J and Nishino H: Prevention of N-methylnitrosourea-induced colon carcinogenesis in F344 rats by lycopene and tomato juice rich in lycopene. Jpn J Cancer Res. 89:1003–1008. 1998. View Article : Google Scholar : PubMed/NCBI
34	Giovannucci E: A review of epidemiologic studies of tomatoes, lycopene and prostate cancer. Exp Biol Med (Maywood). 227:852–859. 2002.
35	Pohar KS, Gong MC, Bahnson R, Miller EC and Clinton SK: Tomatoes, lycopene and prostate cancer: A clinician's guide for counseling those at risk for prostate cancer. World J Urol. 21:9–14. 2003.PubMed/NCBI
36	Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C and Georgescu MM: Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics. Cancer Res. 60:1541–1545. 2000.PubMed/NCBI